HF Logo HF Logo
Provider Home / Provider Alerts
Resource Type
Clear All
Filter
Year
Sort By
Showing 37-48 of 156
Provider Alerts - Behavioral Health and Foster Care - Policy, Billing, or Coverage Update - 2022
Four Behavioral Health Home and Community Based Services Transitioning to New Community Oriented Recovery and Empowerment Services

To improve access to rehabilitative care, New York State received federal approval to transition four Behavioral Health Home and Community Based Services (BH HCBS) to a new service array called Community Oriented Recovery and Empowerment (CORE) Services starting February 1, 2022.

Open document
Mental & Behavioral Health
  
Provider Alerts - Claims & Billing - Policy, Billing, or Coverage Update - 2022
Healthfirst Reimbursement Policy Updates - Effective March 1, 2022

As a part of Healthfirst’s continuing efforts to ensure that our reimbursement policy standards are up to date and compliant with state and national industry standards, our reimbursement policy will undergo several changes effective March 1, 2022. These changes will maintain compliance with industry-accepted coding and reimbursement practices, as well as with state and national regulatory requirements.

Open document
Documentation
  
Provider Alerts - Claims & Billing - Policy, Billing, or Coverage Update - 2022
Changes to Authorization Guidelines for Selected Medical Services

Effective April 1, 2022, Healthfirst will change its authorization guidelines for selected medical services. These changes are part of Healthfirst’s ongoing responsibility to evaluate its medical policies compared to the latest scientific evidence and specialty society guidance.

Open document
Prior Authorization
  
Provider Alerts - Coronavirus (COVID-19) - Policy, Billing, or Coverage Update - 2022
New York Medicaid Guidance for Billing Monoclonal Antibody Treatments

New York State (NYS) Medicaid will reimburse NY Medicaid-enrolled pharmacies for administration or dispensing of COVID-19 therapeutics, including monoclonal antibody (mAb) treatments with no member cost share.

Open document
COVID-19
  
Provider Alerts - Policy, Billing, or Coverage Update - 2022
Prior Authorization Waiver Expiration: Post-Acute Discharge

Effective December 31, 2021, Healthfirst has waived authorization requirements for transfers or discharges from an acute inpatient facility to another acute inpatient facility, a skilled nursing facility (SNF), acute rehabilitation facility (AR), or long-term acute care hospital (LTACH).

Open document
Prior Authorization
  
Provider Alerts - Policy, Billing, or Coverage Update - 2022
Healthfirst Reimbursement of Developmental Screening in Primary Care

Effective April 1, 2022, Healthfirst will begin to reimburse Developmental Screening (CPT 96110) in primary care as per New York State Medicaid guidance.

Open document
Reimbursement
  
Provider Alerts - Claims & Billing - Policy, Billing, or Coverage Update - 2022
Healthfirst Policy for the Authorization of Applied Behavioral Analysis (ABA) Services

Healthfirst’s medical policies are intended to provide guidance in the administration of Healthfirst’s benefit plans and are used by medical directors and other clinical professionals in making medical necessity and other coverage determinations. This policy is applicable to the Commercial Plan, Qualified Health Plan (QHP), Essential Plan (EP) and Child Health Plus (CHP). While this service is not covered by Healthfirst Medicaid Managed Care Plan, ABA services are available to Medicaid beneficiaries through Medicaid Fee-for-Service.

Open document
Billing
  
Provider Alerts - Claims & Billing - Policy, Billing, or Coverage Update - 2022
Billing Guidance for Acupuncturists

Medicare covers acupuncture for chronic lower back pain. Plans must offer this benefit and can choose to offer a supplemental benefit in addition to the original Medicare-covered visits. Previously, most Healthfirst providers submitted claims for acupuncture visits using ICD-10 M54.5. However, this ICD was retired on October 1, 2021.

Open document
Billing
  
Provider Alerts - Claims & Billing - Behavioral Health and Foster Care - Policy, Billing, or Coverage Update - 2022
Child HCBS Authorizations and Reminder of State Billing and Claiming Requirements

This notice is to remind Children’s Home and Community-Based Services (HCBS) providers of HCBS billing and claiming requirements, per the April 4, 2022, NYSDOH memo.

Open document
Billing
  
Provider Alerts - Coronavirus (COVID-19) - Pharmacy Resources & Formularies - Provider Resources - 2023
New York State Medicaid Coverage Criteria for Pharmacists Providing COVID-19 Vaccine Counseling

The New York State Department of Health issued guidance that New York State Medicaid will reimburse COVID-19 vaccination counseling to Medicaid members/enrollees by pharmacists in order to encourage vaccination against COVID-19. The effective date of coverage is for dates of service on or after December 1, 2021.

Open document
Medicaid
  
Provider Alerts - Coronavirus (COVID-19) - Pharmacy Resources & Formularies - Provider Resources - 2023
New York Medicaid COVID-19 Vaccine Claims Submission Reminder

This information is being provided to assist your pharmacy with the submission of COVID-19 vaccine administration claims. The content of this communication is for informational purposes only and is not intended as a substitute for the information provided in the COVID-19 Vaccine Administration Network Enrollment Form.

Open document
Medicaid
  
Provider Alerts - Coronavirus (COVID-19) - Practice Guidelines and Tips - 2022
NYSDOH Issues Advisory: Sotrovimab No Longer Authorized to Treat COVID-19 in Any U.S. Region – Pause in Distribution

The New York State Department of Health (NYSDOH) issued an Advisory on March 25, 2022, announcing a pause in the distribution of sotrovimab.

Open document
COVID-19
  
You are now navigating away from the Healthfirst website.

Links to non-Healthfirst websites are provided for your convenience only. Healthfirst is not responsible or liable for the content, accuracy, or privacy practices of linked sites, or for products or services described on these sites.